Robins Harlan S
Adaptive Biotechnologies Corporation · Chief Scientific Officer
Robins Harlan S is listed in filings as Chief Scientific Officer at Adaptive Biotechnologies Corporation. This profile follows SEC Form 4 activity through Jun 17, 2026, including sale activity. Recent filings connect the profile to Adaptive Biotechnologies Corporation (ADPT). The current snapshot covers public activity from Mar 26, 2025 to Jun 17, 2026. Reported amounts are shown as $110.9K to $15.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2M100k shares | SellJun 15, 2026 | $17.37 | $21.86 | |
| $15k1.7k shares | SellMar 24, 2025 | $9.00 | $21.86 | |
| $503k68.4k shares | SellMay 1, 2025 | $7.35 | $21.86 | |
| $148k10k shares | SellNov 10, 2025 | $14.82 | $21.86 | |
| $166k10k shares | SellDec 4, 2025 | $16.61 | $21.86 | |
| $506k27.2k shares | SellDec 3, 2025 | $18.61 | $21.86 | |
| $164k10k shares | SellJan 6, 2026 | $16.44 | $21.86 | |
| $154k8.1k shares | SellFeb 3, 2026 | $19.00 | $21.86 | |
| $645k34.7k shares | SellFeb 2, 2026 | $18.60 | $21.86 | |
| $235k14.2k shares | SellMar 3, 2026 | $16.52 | $21.86 | |
| $157k10k shares | SellMar 2, 2026 | $15.72 | $21.86 | |
| $4M329.6k shares | SellMar 11, 2026 | $13.17 | $21.86 | |
| $2M140.7k shares | SellMar 11, 2026 | $13.17 | $21.86 | |
| $149k10k shares | SellApr 8, 2026 | $14.85 | $21.86 |